Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Acute lymphoblastic leukemia in adolescent and young adults: treat as adults or as children?

Boissel N, Baruchel A.

Blood. 2018 Jul 26;132(4):351-361. doi: 10.1182/blood-2018-02-778530. Epub 2018 Jun 12. Review.

2.

How should we treat the AYA patient with newly diagnosed ALL?

Boissel N.

Best Pract Res Clin Haematol. 2017 Sep;30(3):175-183. doi: 10.1016/j.beha.2017.07.008. Epub 2017 Aug 3. Review.

PMID:
29050690
3.

How I treat acute lymphoblastic leukemia in older adolescents and young adults.

Curran E, Stock W.

Blood. 2015 Jun 11;125(24):3702-10. doi: 10.1182/blood-2014-11-551481. Epub 2015 Mar 24. Review. Erratum in: Blood. 2015 Oct 8;126(15):1868. Dosage error in article text.

4.

Acute lymphoblastic leukemia and lymphoblastic lymphoma in adolescents and young adults.

McNeer JL, Bleyer A.

Pediatr Blood Cancer. 2018 Jun;65(6):e26989. doi: 10.1002/pbc.26989. Epub 2018 Feb 8. Review.

PMID:
29418064
5.

[Adolescents and young adults with acute lymphoblastic leukemia. A specific management].

Boissel N, Ducassou S.

Bull Cancer. 2017 Jul - Aug;104(7-8):683-689. doi: 10.1016/j.bulcan.2017.03.002. Epub 2017 May 31. French.

PMID:
28576259
6.

[Acute lymphoblastic leukemia in adolescents and young adults].

Hayakawa F.

Rinsho Ketsueki. 2015 Oct;56(10):2032-8. doi: 10.11406/rinketsu.56.2032. Review. Japanese.

PMID:
26458442
7.

Treatment of Young Adults with Acute Lymphoblastic Leukemia.

Kansagra A, Litzow M.

Curr Hematol Malig Rep. 2017 Jun;12(3):187-196. doi: 10.1007/s11899-017-0377-y. Review.

PMID:
28353017
8.

Acute lymphoblastic leukemia in adolescents and young adults.

Rytting ME, Jabbour EJ, O'Brien SM, Kantarjian HM.

Cancer. 2017 Jul 1;123(13):2398-2403. doi: 10.1002/cncr.30624. Epub 2017 Mar 22. Review.

9.

Closing the gap: Novel therapies in treating acute lymphoblastic leukemia in adolescents and young adults.

Friend BD, Schiller GJ.

Blood Rev. 2018 Mar;32(2):122-129. doi: 10.1016/j.blre.2017.09.005. Epub 2017 Sep 21. Review.

PMID:
28969872
10.

Graft-Versus-Host Disease in Adolescents and Young Adults (15-24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission.

Vignon M, Andreoli A, Dhédin N, Lengliné E, Masson E, Robin M, Granier C, Larghero J, Schlageter MH, de Latour RP, Socié G, Boissel N.

J Adolesc Young Adult Oncol. 2017 Jun;6(2):299-306. doi: 10.1089/jayao.2016.0060. Epub 2016 Dec 16.

PMID:
27983886
11.

Acute lymphoblastic leukemia in young adults: which treatment?

McNeer JL, Raetz EA.

Curr Opin Oncol. 2012 Sep;24(5):487-94. doi: 10.1097/CCO.0b013e32835538f8. Review.

PMID:
22691923
12.

Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma.

Kahn JM, Keegan TH, Tao L, Abrahão R, Bleyer A, Viny AD.

Cancer. 2016 Sep 1;122(17):2723-30. doi: 10.1002/cncr.30089. Epub 2016 Jun 10.

13.

Treatment strategies for adolescent and young adult patients with acute myeloid leukemia.

O'Dwyer K, Freyer DR, Horan JT.

Blood. 2018 Jul 26;132(4):362-368. doi: 10.1182/blood-2017-12-778472. Epub 2018 Jun 12. Review.

14.

Progress in the treatment of adults with acute lymphoblastic leukemia.

Larson S, Stock W.

Curr Opin Hematol. 2008 Jul;15(4):400-7. doi: 10.1097/MOH.0b013e3283034697. Review.

PMID:
18536580
15.

Adolescents and young adults with acute lymphoblastic leukemia.

Stock W.

Hematology Am Soc Hematol Educ Program. 2010;2010:21-9. doi: 10.1182/asheducation-2010.1.21. Review.

PMID:
21239766
16.

Evolving paradigms in the therapy of Philadelphia-chromosome-negative acute lymphoblastic leukemia in adults.

Litzow MR.

Hematology Am Soc Hematol Educ Program. 2009:362-70. doi: 10.1182/asheducation-2009.1.362. Review.

PMID:
20008222
17.

Risk-Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults.

Guzauskas GF, Villa KF, Vanhove GF, Fisher VL, Veenstra DL.

J Adolesc Young Adult Oncol. 2017 Mar;6(1):53-61. doi: 10.1089/jayao.2016.0049. Epub 2016 Oct 25.

18.

Survival improvements in adolescents and young adults after myeloablative allogeneic transplantation for acute lymphoblastic leukemia.

Wood WA, Lee SJ, Brazauskas R, Wang Z, Aljurf MD, Ballen KK, Buchbinder DK, Dehn J, Freytes CO, Lazarus HM, Lemaistre CF, Mehta P, Szwajcer D, Joffe S, Majhail NS.

Biol Blood Marrow Transplant. 2014 Jun;20(6):829-36. doi: 10.1016/j.bbmt.2014.02.021. Epub 2014 Mar 7.

19.

Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.

Ram R, Storb R, Sandmaier BM, Maloney DG, Woolfrey A, Flowers ME, Maris MB, Laport GG, Chauncey TR, Lange T, Langston AA, Storer B, Georges GE.

Haematologica. 2011 Aug;96(8):1113-20. doi: 10.3324/haematol.2011.040261. Epub 2011 Apr 20.

20.

Acute lymphoblastic leukemia in adolescents and young adults.

Ribera JM, Oriol A.

Hematol Oncol Clin North Am. 2009 Oct;23(5):1033-42, vi. doi: 10.1016/j.hoc.2009.07.002. Review.

PMID:
19825451

Supplemental Content

Support Center